Skip to search formSkip to main contentSkip to account menu

ethylphenidate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
OBJECTIVE In the last decades, several cognitive-enhancing drugs have been sold onto the drug market. Methylphenidate and analogs… 
Review
2015
Review
2015
The urge to gain information on a new drug marketed online as ‘Psyclone’ has emerged after the death of a 38‐year‐old man in… 
2015
2015
Ethylphenidate is a novel psychoactive substance with undocumented effects, risks, and motivation for use. In this study, we… 
Review
2014
Review
2014
We review the pharmaceutical science of ethylphenidate (EPH) in the contexts of drug discovery, drug interactions, biomarker for… 
2011
2011
We tested the hypothesis that C57BL/6J mice will model human metabolic interactions between dl-methylphenidate (MPH) and ethanol… 
2010
2010
Abstract In view of the widespread application of methylphenidate for attention-deficit/hyperactivity disorder (ADHD) therapy its… 
2007
2007
Ethylphenidate is formed by metabolic transesterification of methylphenidate and ethanol. Study objectives were to (a) establish… 
2005
2005
Ethanol elevates methylphenidate (1) plasma concentrations and yields the metabolite ethylphenidate (2). The therapeutic…